Newsletter

226950 - Olix Pharmaceuticals, Inc.

226950 Summary
Biopharma
Stock Price & Overview
₩95,900 +4,100 (+4.47%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩95,900  ≈ US$69  ·  Market cap ₩2.0tn (≈ $1.4bn)
Why this page exists. Korean issuers file to DART, not the SEC, and almost nothing is published in English. Titles here are translated; where kstock has read the filing, the row carries the explanation and the amount in won and dollars. How we pick »

226950 DART Filings

DART

Exercise of a conversion right on convertible shares

Filing09/01/26title translated
DART

Exercise of a conversion right on convertible shares

Filing08/31/26title translated
DART

Material matter affecting investment judgment

Filing08/21/26title translated
DART

Half-Year Report

Periodic08/14/26title translated
DART

Grant of stock options ×3

Filing08/12/26title translated
DART

Material matter affecting investment judgment

Filing08/04/26title translated
DART

Results of an extraordinary general meeting

Filing07/30/26title translated
DART

Proxy solicitation reference document

Filing07/16/26title translated
DART

Notice of general meeting of shareholders

Filing07/16/26title translated
DART

Proxy solicitation reference document

Filing07/15/26title translated
DART

Notice of general meeting of shareholders

Filing07/15/26title translated
DART

Resolution to convene an extraordinary general meeting

Filing07/15/26title translated
DART

Grant of stock options

Filing07/15/26title translated
DART

Securities issuance result (voluntary)

Filing07/08/26title translated
DART

Material event report (paid-in capital increase)

Filing07/08/26title translated
DART

Material event report (paid-in capital increase) ×2

Filing06/29/26title translated
DART

Securities issuance result (voluntary)

Filing06/29/26title translated
DART

Material event report (paid-in capital increase)

Filing06/01/26title translated
DART

Record date set, shareholder register closed

Filing06/01/26title translated
DART

Quarterly Report

Periodic05/15/26title translated
8 routine filings (insider holdings reports, IR schedules)DART

5% Ownership Report — Short Form

Ownership09/01/26title translated
DART

Insider / Major Shareholder Holdings Report

Ownership08/28/26title translated
DART

5% Ownership Report — Short Form

Ownership08/10/26title translated
DART

5% Ownership Report — Short Form

Ownership08/03/26title translated
DART

5% Ownership Report — Short Form

Ownership07/07/26title translated
DART

Investor Relations Event

IR06/15/26title translated
DART

5% Ownership Report — Large Holdings

Ownership06/01/26title translated
DART

Insider / Major Shareholder Holdings Report ×3

Ownership06/01/26title translated
28 filings on file, grouped where one event produced many. Source: DART, operated by Korea's Financial Supervisory Service.

Similar to 226950

SymbolLast Price
009420Hanall Biopharma Co., Ltd.₩54,700
+1.5%
310210Voronoi, Inc.₩153,000
+3.9%
214370Caregen Co., Ltd.₩44,500
+1.5%
347850D & D Pharmatech, Inc.₩49,200
+1.4%
237690ST Pharm Co., Ltd.₩101,200
+2.2%
140410Mezzion Pharma Co., Ltd.₩65,000
+0.0%
068760Celltrion Pharm, Inc.₩40,850
+0.0%
007390Naturecell Co., Ltd.₩23,950
+0.2%
006280GC Biopharma Corp.₩127,600
+0.5%
950160Kolon Tissue Gene, Inc.₩17,100
+1.1%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.